Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FAKNV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,046
Award facts
- Contract value 100% obligated
- $47,046.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $47,046.16 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2ml pen format, with an ultimate completion date of January 22, 2026. This firm fixed-price contract, awarded on January 21, 2026, represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999 through December 2026. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to compete on a full and open basis. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), serves as a critical pharmaceutical distributor for federal military healthcare programs. The delivery of Cosentyx, a specialty immunosuppressant medication used to treat conditions such as psoriasis and ankylosing spondylitis, supports the Defense Health Agency's medical supply requirements across military treatment facilities. AmerisourceBergen's extensive portfolio under the DLA prime contract encompasses brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains, enabling the company to fulfill diverse medical procurement needs for military and veteran healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26FAKNV?
SPE2DR26FAKNV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FAKNV worth?
The government has obligated $47,046 on SPE2DR26FAKNV.
Is contract SPE2DR26FAKNV an order under another contract?
Yes. SPE2DR26FAKNV is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAKNV competed?
The extent of competition for SPE2DR26FAKNV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award